Novel biomarker panel predicts prognosis in human papillomavirus‐negative oropharyngeal cancer
Yin Wu(Yangzhou University), Kevin J. Cullen(University of Maryland, Baltimore), Ming Tan(University of Maryland, Baltimore), Nicholas J. Sarlis(Incyte (United States)), Sana Iqbal(Detroit Medical Center), Jochen H. Lorch(Northwestern University), Robert I. Haddad(Georgetown University), Lisa M. Schumaker, Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Changwan Lu(University of Maryland, Baltimore), Nikolaos G. Nikitakis(National and Kapodistrian University of Athens), Olga Goloubeva(University of Maryland, Baltimore)
Cited by 29
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926